Funded Tech Companies
Accent Therapeutics
Headquartered in Lexington, Accent Therapeutics has funding from AbbVie Biotech Ventures, GV and Mirae Asset Venture Investment.
Company Overview
Company Name
Accent Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
65 Hayden Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Company Background Information
Overview
Accent Therapeutics is a biopharmaceutical company developing oncology-focused, small molecule therapies in the emerging field of epitranscriptomics.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/23/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Shakti Narayan
Chief Financial Officer
Nicole Heifner
President
Robert Copeland
Vice President
Ann Boriack-Sjodin
Vice President
Kenneth Duncan
Vice President
Scott Ribich
VP - Bus. Development
David Brower
Company Investors
- AbbVie Biotech Ventures
- GV
- Mirae Asset Venture Investment
- The Column Group (Larry Lasky)
- NS Investment
- Atlas Venture (Jason Rhodes)
- Droia Ventures
- EcoR1 Capital Management (Oleg Nodelman)
- Mirae Asset Capital
- Bristol Myers Squibb
- Johnson & Johnson Innovation
- The Mark Foundation for Cancer Research
- DROIA
Browse more funded tech companies:
Accend Technology | AccentCare
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs